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LOW LEVEL LASER REDUCES THE SEVERITY OF RADIOTHERAPY 
INDUCED ORAL MUCOSITIS AND XEROSTOMIA 
Ana Ortega Lopez MD, Univ. of Hawaii Pathology Residency Program, 
originally from Spain 
• Studies directed by Dr. Josepha Rigau 
• Mucositis and xerostomia are common reasons to have to halt 
radiotherapy or decrease the dose 
• Many topical drugs, oral drugs have been tried 
• Soft laser therapy (InGaAIP laser) 685 nm, 50 mW, output power mw, 
application size 2J/cm2 
• 3 application points on jaw, 2 buccal mucosa each side, 3 pharynx, 4 on 
tongue 
• No application points over the tumor, did not want to activate 
• 60 patients 
• Radiotherapy daily 1.8-2.0 Gy, total dose 45-72 GY 
• Many received cisplatinum weekly therapy 
• Done in Brazil, randomized 
• Most had squamous cell cancer 
• Used a grading o oral mucositis, done weekly (NCI scores) 
o 0=none 
o 4=life-threatening 
• Used a pain score, 1-10 
• Salivary flow rate was measures at day 1 (basal, day 15, at end of 
treatment, and 15 and 30 days after TX was completed 
• Statistical analysis 
Results: 
• NCI scores: baseline approx 0.3, without laser was 2, and less than one 
with laser 
• Pain scores 2 without laser, 07-0.9 with laser throughout the treatment 
• Salivation: without laser had significant decreased saliva production, 
treated with laser maintained their salivary flow rate 
• Stimulated salivary flow rate: same results 
Pathology slides:  
• See more atrophy of salivary gland cells and larger loss of acini if no laser 
therapy is given 
• Radiotherapy alone: pathology shows more chronic inflammation than 
those who received laser treatment 
• Less fibrosis, more serous cells with laser 
One-year follow-up:  
• Radiotherapy alone: loss of salivary flow has been permanent 
• With laser therapy: have been able to maintain their salivary flow 
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• Plan to follow these patients for six years 
Conclusions: 
• The incidence of xerostomia is significantly reduced in patients treated 
with radiotherapy with laser 
• The use of laser in combination with radiotherapy decreases the severity 
of oral mucositis 
• The pain associated the oral mucositis is also reduced significantly in 
patients treated with radiotherapy with laser 
Discussion: 
• Did you try to treat the cancer? No, because clinical experience suggests 
that the laser activates the cancer. 
• Work in rats: can use ankophorin (sp?) to restore salivation knocked out 
by radiotherapy 
• How did you choose the target spots?  Followed the same pattern of 
previous studies.  It is the idea of the vascular areas that supply the 
glands. 
• Would this work after the radiotherapy is complete?  Harry Wayland has 
not a similar study with children, use a light box externally on the outside 
of the cheek, use in pt. with any kind of cancer but who develop 
xerostomia after radiation, they have had very good results 
• Paul Bradley: many groups are working on this, but this study shows 
treating the salivary glands directly.  The French have treated the patient 
before the radiotherapy begins and have found a protective effect.  In this 
study the principal investigator is a radiotherapist so he does not see them 
before. 
• Paul Bradley: Russian Skibelkin has done animal studies: laser can treat 
cancer.  Mikilov: cancer of esophagus: radiotherapy, no TX, LLLT; the 
LLLT group did the best but were creative in watching and treating the 
immune system, would irradiate the spleen etc. 
 
